Home▸Shingles (Herpes Zoster) & Mononucleosis▸VZV Reactivation Mechanism Simulator

🔥 VZV Reactivation Mechanism Simulator

A simulation of the reactivation mechanism of latent varicella-zoster virus in dorsal root ganglia through age-related decline in cellular immunity, with spread to dermatome.

Shingles (Herpes Zoster) & Mononucleosis2DModerate60 FPS
vzv-reactivation-mechanism-simulator ↗ Open standalone

Latent Reservoir in the Dorsal Root Ganglion

Placeholder: VZV hides quietly inside sensory neuron cell bodies for decades.

  • DRG: Latency site (Placeholder short note)
  • Episomal: Genome form (Placeholder short note)
  • Minimal: Gene expression (Placeholder short note)
  • Decades: Duration (Placeholder short note)

Establishing latency

Placeholder: primary varicella seeds ganglia via retrograde axonal transport.

Immune containment

Placeholder: resident T-cells keep the latent virus permanently suppressed.

Placeholder key insight: latency is stable while surveillance stays strong.

Age-Related Decline of Systemic Immunity

Placeholder: aging thymic output and immune diversity shrink over time.

  • ↓ with age: Thymic output (Placeholder short note)
  • Declining: Naive T-cells (Placeholder short note)
  • ~50yrs: Risk onset (Placeholder short note)
  • >60yrs: Peak incidence (Placeholder short note)

Immunosenescence drivers

Placeholder: thymic involution reduces new antigen-specific T-cell supply.

Population risk curve

Placeholder: shingles incidence rises steadily after age fifty.

Placeholder key insight: age is the strongest single risk factor.

Loss of VZV-Specific Cell-Mediated Immunity

Placeholder: VZV-specific T-cell clones shrink and lose potency.

  • ↓ decades: VZV-CMI (Placeholder short note)
  • Reduced: Boosting (Placeholder short note)
  • Stable: Antibody titer (Placeholder short note)
  • T-cells: Key defense (Placeholder short note)

Why T-cells matter most

Placeholder: antibodies alone cannot control intracellular latent virus.

Threshold for control

Placeholder: below a critical CMI level, suppression fails.

Placeholder key insight: CMI decline, not antibody loss, drives shingles.

Viral Reactivation and Anterograde Axonal Transport

Placeholder: unchecked virus replicates and travels down the axon.

  • Anterograde: Transport (Placeholder short note)
  • Sensory nerve: Site (Placeholder short note)
  • Neuralgia: Symptom (Placeholder short note)
  • Days: Onset (Placeholder short note)

Reactivation trigger

Placeholder: weakened surveillance allows lytic gene expression to resume.

Axonal spread

Placeholder: virions move along the nerve toward the skin.

Placeholder key insight: pain often precedes visible rash by days.

Dermatome-Confined Vesicular Eruption

Placeholder: rash appears strictly within one sensory dermatome band.

  • Unilateral: Pattern (Placeholder short note)
  • 1 dermatome: Distribution (Placeholder short note)
  • Vesicles: Lesion type (Placeholder short note)
  • PHN risk: Complication (Placeholder short note)

Dermatomal confinement

Placeholder: rash follows the single ganglion nerve's skin territory.

Clinical course

Placeholder: vesicles crust over one to two weeks typically.

Placeholder key insight: postherpetic neuralgia risk rises steeply with age.
⚙ Under the hood

A simulation of the reactivation mechanism of latent varicella-zoster virus in dorsal root ganglia through age-related decline in cellular immunity, with spread to dermatome.

CanvasBiomedicine

2D · HTML5 Canvas 2D · 60 FPS target · runs fully client-side, no install

What did you find?

Add reproduction steps (optional)